Clinical impact of 'in-treatment' wall motion abnormalities in hypertensive patients with left ventricular hypertrophy: The LIFE study Academic Article uri icon

Overview

MeSH Major

  • Antihypertensive Agents
  • Hypertension
  • Hypertrophy, Left Ventricular
  • Losartan

abstract

  • In hypertensive patients with LVH and no history of cardiovascular disease, 'in-treatment' left ventricular wall motion abnormalities are associated with increased likelihood of subsequent cardiovascular events independent of age, gender, blood pressure lowering, treatment modality, and in-treatment left ventricular mass index.

publication date

  • April 2008

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1097/HJH.0b013e3282f4b3a9

PubMed ID

  • 18327092

Additional Document Info

start page

  • 806

end page

  • 12

volume

  • 26

number

  • 4